Published in Trans R Soc Trop Med Hyg on December 07, 1992
Leishmaniases of the New World: current concepts and implications for future research. Clin Microbiol Rev (1993) 2.37
PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. J Clin Microbiol (1995) 1.83
Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity. Infect Immun (1998) 1.20
Identification of potentially diagnostic Leishmania braziliensis antigens in human cutaneous leishmaniasis by immunoblot analysis. Clin Diagn Lab Immunol (2000) 0.91
Is Leishmania (Viannia) braziliensis preferentially restricted to the cutaneous lesions of naturally infected dogs? Parasitol Res (2005) 0.78
Low-cost liquid medium for in vitro cultivation of Leishmania parasites in low-income countries. Glob Health Action (2009) 0.75
Epidemiological study of cutaneous leishmaniasis in Saesie Tsaeda-emba district, eastern Tigray, northern Ethiopia. Parasit Vectors (2015) 0.75
Humoral immune response in human syphilis to polypeptides of Treponema pallidum. J Immunol (1982) 2.99
Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination. Clin Exp Immunol (2001) 2.43
Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole. Nature (1999) 2.03
Purification and characterization of a cloned protease-resistant Treponema pallidum-specific antigen. Infect Immun (1984) 1.80
Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS (1998) 1.69
The surface of virulent Treponema pallidum: resistance to antibody binding in the absence of complement and surface association of recombinant antigen 4D. Infect Immun (1986) 1.61
The role of nerve biopsies in the diagnosis and management of leprosy. Lepr Rev (1989) 1.53
Tribal differences in perception of tuberculosis: a possible role in tuberculosis control in Arusha, Tanzania. Int J Tuberc Lung Dis (2003) 1.51
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS (1999) 1.40
Native surface association of a recombinant 38-kilodalton Treponema pallidum antigen isolated from the Escherichia coli outer membrane. Infect Immun (1986) 1.39
RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity (1999) 1.39
Antibody-secreting cell precursor frequencies among the sheep-erythrocyte-binding cells after immunization. Scand J Immunol (1983) 1.37
Species differences in V1a receptor gene expression in monogamous and nonmonogamous voles: behavioral consequences. Behav Neurosci (1997) 1.32
Immunization of rabbits with recombinant Treponema pallidum surface antigen 4D alters the course of experimental syphilis. J Immunol (1988) 1.32
Leishmania-HIV interaction: immunopathogenic mechanisms. Parasitol Today (1999) 1.31
Computerized assessment of production of multiple human cytokines at the single-cell level using image analysis. J Leukoc Biol (1996) 1.27
Mycobacterial adenitis: role of Mycobacterium bovis, non-tuberculous mycobacteria, HIV infection, and risk factors in Arusha, Tanzania. East Afr Med J (2004) 1.27
Properties of an ordered ring structure formed by recombinant Treponema pallidum surface antigen 4D. J Bacteriol (1986) 1.25
Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol (2001) 1.24
The Swedish snus and the Sudanese toombak: are they different? Oral Oncol (1998) 1.22
Genetic variability within the species Leishmania aethiopica does not correlate with clinical variations of cutaneous leishmaniasis. Mol Biochem Parasitol (2000) 1.21
Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity. Infect Immun (1998) 1.20
Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T-cell clones. Infect Immun (1987) 1.20
Low dose chronic Schistosoma mansoni infection increases susceptibility to Mycobacterium bovis BCG infection in mice. Clin Exp Immunol (2005) 1.18
Serodiagnosis of syphilis by enzyme-linked immunosorbent assay with purified recombinant Treponema pallidum antigen 4D. J Infect Dis (1986) 1.17
A mouse model for slowly progressive primary tuberculosis. Scand J Immunol (1999) 1.16
PPD induced in vitro interferon gamma production is not a reliable correlate of protection against Mycobacterium tuberculosis. Trans R Soc Trop Med Hyg (2005) 1.14
Toombak use and cigarette smoking in the Sudan: estimates of prevalence in the Nile state. Prev Med (1998) 1.09
HIV viral load and response to antileishmanial chemotherapy in co-infected patients. AIDS (1999) 1.06
Role of disulfide bonds in the oligomeric structure and protease resistance of recombinant and native Treponema pallidum surface antigen 4D. J Bacteriol (1987) 1.06
Species differences in central oxytocin receptor gene expression: comparative analysis of promoter sequences. J Neuroendocrinol (1996) 1.05
Live Leishmania promastigotes can directly activate primary human natural killer cells to produce interferon-gamma. Clin Exp Immunol (2003) 1.05
Immune responses to fractionated cytomegalovirus (CMV) antigens after HIV infection. Loss of cellular and humoral reactivity to antigens recognized by HIV-, CMV+ individuals. Clin Exp Immunol (1990) 1.05
Differential recognition of Leishmania aethiopica antigens by lymphocytes from patients with local and diffuse cutaneous leishmaniasis. Evidence for antigen-induced immune suppression. J Immunol (1988) 1.03
A Leishmania homologue of receptors for activated C-kinase (LACK) induces both interferon-gamma and interleukin-10 in natural killer cells of healthy blood donors. J Infect Dis (2000) 1.02
Helminthes could influence the outcome of vaccines against TB in the tropics. Parasite Immunol (2006) 1.02
Increased expression of fas ligand in human tuberculosis and leprosy lesions: a potential novel mechanism of immune evasion in mycobacterial infection. Scand J Immunol (2001) 1.01
Role of Leishmania donovani and its lipophosphoglycan in CD4+ T-cell activation-induced human immunodeficiency virus replication. Infect Immun (1999) 0.97
The role of livestock keeping in tuberculosis trends in Arusha, Tanzania. Int J Tuberc Lung Dis (2003) 0.97
A mouse model for latent tuberculosis. Scand J Infect Dis (1998) 0.96
HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani. AIDS (2000) 0.94
Increased Bcl-2 and reduced Bax expression in infected macrophages in slowly progressive primary murine Mycobacterium tuberculosis infection. Scand J Immunol (2002) 0.93
Leishmania surface protein gp63 binds directly to human natural killer cells and inhibits proliferation. Clin Exp Immunol (2008) 0.93
Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: a potential novel mechanism of immune evasion by Mycobacterium tuberculosis? Inflammation (1999) 0.92
Emerging Leishmania/HIV co-infection in Africa. Med Microbiol Immunol (2001) 0.92
In situ characterization of mononuclear cells in human dental periapical inflammatory lesions using monoclonal antibodies. Oral Surg Oral Med Oral Pathol (1984) 0.92
Benign cementoblastoma. Int J Oral Surg (1979) 0.92
The value of a direct agglutination test in the diagnosis of cutaneous and visceral leishmaniasis in Ethiopia. Trans R Soc Trop Med Hyg (1991) 0.90
Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis. Parasite Immunol (1990) 0.90
Live and killed human immunodeficiency virus type-1 increases the intracellular growth of Leishmania donovani in monocyte-derived cells. Scand J Infect Dis (1998) 0.90
Comparative detection frequency of 6 putative periodontal pathogens in Sudanese and Norwegian adult periodontitis patients. J Periodontol (1994) 0.90
Characterization of mononuclear cells in sarcoid skin lesions using monoclonal antibodies. Acta Pathol Microbiol Immunol Scand C (1983) 0.89
Patient knowledge, practices and challenges to health care system in early diagnosis of mycobacterial adenitis. East Afr Med J (2005) 0.88
Alteration of Fas and Fas ligand expression during human visceral leishmaniasis. Clin Exp Immunol (2002) 0.88
Differential induction of cellular responses by live and dead Leishmania promastigotes in healthy donors. Clin Exp Immunol (2001) 0.87
Localization of Fc gamma receptors in the human central nervous system. Acta Pathol Microbiol Immunol Scand C (1982) 0.86
In situ expression of cytokines and cellular phenotypes in the lungs of mice with slowly progressive primary tuberculosis. Scand J Immunol (2000) 0.86
Induction and abrogation of LACK reactive cells in the evolution of human leishmaniasis. Clin Exp Immunol (2001) 0.85
The 5' flanking region of the monogamous prairie vole oxytocin receptor gene directs tissue-specific expression in transgenic mice. Ann N Y Acad Sci (1997) 0.85
Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: lack of association with human papillomavirus infection. APMIS (1998) 0.85
Targeted suppression of cytokine production in monocytes but not in T lymphocytes by a tetravalent guanylhydrazone (CNI-1493). J Infect Dis (1997) 0.84
Skin rash for 15 years. Lancet (1998) 0.84
Differences in PCR reactivity between HIV proviruses from individuals in Ethiopia and Sweden. J Acquir Immune Defic Syndr (1990) 0.84
The pathogenesis of Leishmania aethiopica infection in BALB/c mice. Scand J Immunol (1990) 0.83
Enzyme histochemistry of induced heterotropic bone formation in guinea-pigs. Arch Oral Biol (1979) 0.83
Systems biology of the neurospora biological clock. IET Syst Biol (2007) 0.82
HIV-1 inhibits Leishmania-induced cell proliferation but not production of interleukin-6 and tumour necrosis factor alpha. Scand J Immunol (1994) 0.82
Immune reactivity to fractionated Leishmania aethiopica antigens during active human infection. J Clin Microbiol (1991) 0.82
In situ characterization of mononuclear cells in human chronic marginal periodontitis using monoclonal antibodies. J Periodontal Res (1986) 0.82
In situ localization of interferons in psoriatic lesions. Arch Dermatol Res (1989) 0.82
Localization of Fc gamma receptors and complement receptors CR1 on human peripheral nerve fibres by immunoelectron microscopy. J Neuroimmunol (1989) 0.81
HIV-1 exposed dendritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation. AIDS (1999) 0.81
Ameloblastic fibroma. Int J Oral Surg (1979) 0.81
Mutations of the p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from the Sudan and Scandinavia. Int J Cancer (1999) 0.80
Microbial associations of 4 putative periodontal pathogens in Sudanese adult periodontitis patients determined by DNA probe analysis. J Periodontol (1994) 0.80
Isolation in cell culture of nodavirus from farmed Atlantic halibut Hippoglossus hippoglossus in Norway. Dis Aquat Organ (2000) 0.80
In situ characterization of cell infiltrates in human dental periapical granulomas. 2. Demonstration of receptors for the complement components C3b and C3d. J Oral Pathol (1984) 0.80
Quantitative single cell methods that identify cytokine and chemokine expression in dendritic cells. J Immunol Methods (2001) 0.79
In situ characterization of mononuclear cells in marginal periodontitis of patients with Down's syndrome. Acta Odontol Scand (1992) 0.79
Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study. Br J Pharmacol (2015) 0.79
Enzyme histochemical studies of induced heterotopic cartilage and bone formation in guinea pigs with special reference to acid phosphatase. Scand J Dent Res (1981) 0.79
Expression of HLA class II antigens in marginal periodontitis of patients with Down's syndrome. Eur J Oral Sci (1995) 0.79
Changes in the antigenic profile of Leishmania parasites following shifts in temperature. Acta Trop (1990) 0.78
Contribution of human neutrophils in the development of protective immune response during in vitro Leishmania major infection. Parasite Immunol (2011) 0.78
Down-regulation of lymphokine synthesis by intravenous gammaglobulin is dependent upon accessory cells. Scand J Immunol (1998) 0.78
Evaluation of amastigote reactive cells in human cutaneous leishmaniasis caused by Leishmania aethiopica. Clin Exp Immunol (2003) 0.78
Benign fibrous xanthoma of the parotid gland: a case report. Br J Oral Surg (1978) 0.78
The localization of glomerular C3b receptor by immunoelectron microscopy. Scand J Immunol (1982) 0.78
Immunohistochemical detection of p53 in non-malignant and malignant oral lesions associated with snuff dipping in the Sudan and Sweden. Int J Cancer (1996) 0.78
Interaction between hammerhead ribozyme and RNA substrates measured by a surface plasmon resonance biosensor. J Biochem Biophys Methods (2000) 0.77
Oral lesions of epidermolysis bullosa acquisita. Oral Surg Oral Med Oral Pathol (1978) 0.77
Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas. Oral Oncol (1999) 0.77
Epidermolysis bullosa acquisita and Crohn's disease. Acta Derm Venereol (1978) 0.77
A glycosylated Bence Jones protein and its autologous amyloid light chain containing potentially amyloidogenic residues. Scand J Immunol (1998) 0.77
Longitudinal study of cytomegalovirus antibodies in individuals infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis (1995) 0.77
In situ expression of CD40, CD40L (CD154), IL-12, TNF-alpha, IFN-gamma and TGF-beta1 in murine lungs during slowly progressive primary tuberculosis. Scand J Immunol (2003) 0.77
Gamma/delta T lymphocytes in marginal periodontitis in patients with Down's syndrome. Adv Exp Med Biol (1995) 0.76
Leishmanial amastigote antigen P-2 induces major histocompatibility complex class II-dependent natural killer-cell reactivity in cells from healthy donors. Scand J Immunol (2004) 0.76
Characterization of an amorphous deposit in the lamina propria in oral snuff users in the Sudan as collagen. J Oral Pathol Med (1998) 0.76
Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis. Neurology (1999) 0.76